» Articles » PMID: 8701982

Fas Antigen Expression and Its Relationship with Apoptosis in Human Hepatocellular Carcinoma and Noncancerous Tissues

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 1996 Aug 1
PMID 8701982
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Apoptosis, a programmed cell death, can be observed in the tissues of viral or autoimmune hepatitis and of hepatocellular carcinoma. Fas antigen (Fas) was proposed as a protein that triggers apoptosis. To elucidate the relationship between Fas expression and its location in hepatocellular carcinoma cells, we histochemically examined Fas expression by using 25 hepatocellular carcinoma tissues and their corresponding noncancerous tissues, which were surgically obtained from the same patients. In addition, the relationship between Fas expression and apoptotic cell numbers was examined in the hematoxylin-and-eosin-stained specimens obtained from 23 of the 25 patients. Hepatocellular carcinoma tissues expressed Fas less frequently and more weakly than noncancerous tissues. The majority of noncancerous specimens expressed Fas both on the surface and in the cytoplasm, whereas the majority of hepatocellular carcinoma expressed Fas only in the cytoplasm. Apoptotic cell counts were significantly higher in Fas-expressing tissues than in Fas-negative tissues. Among Fas-expressing tissues, the counts were higher in surface Fas-expressing tissues than in tissues that expressed only cytoplasmic Fas (P < 0.01 to 0.05). Our findings indicate that the development of apoptosis in hepatocellular carcinoma tissues relates to not only Fas expression but also its location.

Citing Articles

Hepatitis C Virus and Hepatocellular Carcinoma: When the Host Loses Its Grip.

Goto K, Roca Suarez A, Wrensch F, Baumert T, Lupberger J Int J Mol Sci. 2020; 21(9).

PMID: 32357520 PMC: 7246584. DOI: 10.3390/ijms21093057.


Hepatitis B Virus Surface Antigen Enhances the Sensitivity of Hepatocytes to Fas-Mediated Apoptosis via Suppression of AKT Phosphorylation.

Jing Z, Liu W, Wu S, He Y, Lin Y, Chen W J Immunol. 2018; 201(8):2303-2314.

PMID: 30171166 PMC: 6176106. DOI: 10.4049/jimmunol.1800732.


Bridging the molecular and biological functions of the oxysterol-binding protein family.

Pietrangelo A, Ridgway N Cell Mol Life Sci. 2018; 75(17):3079-3098.

PMID: 29536114 PMC: 11105248. DOI: 10.1007/s00018-018-2795-y.


Interference of Apoptosis by Hepatitis B Virus.

Lin S, Zhang Y Viruses. 2017; 9(8).

PMID: 28820498 PMC: 5580487. DOI: 10.3390/v9080230.


Regulation of cell death receptor S-nitrosylation and apoptotic signaling by Sorafenib in hepatoblastoma cells.

Rodriguez-Hernandez A, Navarro-Villaran E, Gonzalez R, Pereira S, Soriano-De Castro L, Sarrias-Gimenez A Redox Biol. 2015; 6:174-182.

PMID: 26233703 PMC: 4534573. DOI: 10.1016/j.redox.2015.07.010.


References
1.
Suda T, Nagata S . Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med. 1994; 179(3):873-9. PMC: 2191418. DOI: 10.1084/jem.179.3.873. View

2.
Suda T, Takahashi T, Golstein P, Nagata S . Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 1993; 75(6):1169-78. DOI: 10.1016/0092-8674(93)90326-l. View

3.
Mysler E, Bini P, Drappa J, Ramos P, Friedman S, Krammer P . The apoptosis-1/Fas protein in human systemic lupus erythematosus. J Clin Invest. 1994; 93(3):1029-34. PMC: 294028. DOI: 10.1172/JCI117051. View

4.
Cheng J, Zhou T, Liu C, Shapiro J, BRAUER M, Kiefer M . Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science. 1994; 263(5154):1759-62. DOI: 10.1126/science.7510905. View

5.
Radinsky R, Kruzel E, Berry K, Yonehara S . Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res. 1994; 54(6):1580-6. View